Related references
Note: Only part of the references are listed.Understanding Mechanisms of Food Effect and Developing Reliable PBPK Models Using a Middle-out Approach
Xavier J. H. Pepin et al.
AAPS JOURNAL (2021)
A Decade of FDA-Approved Drugs (2010-2019): Trends and Future Directions
Dean G. Brown et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Effect of Polymer Species on Maximum Aqueous Phase Supersaturation Revealed by Quantitative Nuclear Magnetic Resonance Spectroscopy
Keisuke Ueda et al.
MOLECULAR PHARMACEUTICS (2021)
Amorphous Solid Dispersion Tablets Overcome Acalabrutinib pH Effect in Dogs
Deanna M. Mudie et al.
PHARMACEUTICS (2021)
Proton Pump Inhibitors and Oncologic Treatment Efficacy: A Practical Review of the Literature for Oncologists
Angel A. T. Uchiyama et al.
CURRENT ONCOLOGY (2021)
Selection of In Vivo Predictive Dissolution Media Using Drug Substance and Physiological Properties
Deanna M. Mudie et al.
AAPS JOURNAL (2020)
Harnessing the therapeutic potential of anticancer drugs through amorphous solid dispersions
Urvi H. Gala et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)
A Systematic Review of Gastric Acid-Reducing Agent-Mediated Drug-Drug Interactions with Orally Administered Medications
Divya Patel et al.
CLINICAL PHARMACOKINETICS (2020)
In vivo measurement of gastric fluid volume in anesthetized dogs
Cuncai Wang et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2020)
Prediction Characteristics of Oral Absorption Simulation Software Evaluated Using Structurally Diverse Low-Solubility Drugs
Naoya Matsumura et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Practical Approach to Modeling the Impact of Amorphous Drug Nanoparticles on the Oral Absorption of Poorly Soluble Drugs
Aaron M. Stewart et al.
MOLECULAR PHARMACEUTICS (2020)
Novel High-Drug-Loaded Amorphous Dispersion Tablets of Posaconazole; In Vivo and In Vitro Assessment
Deanna M. Mudie et al.
MOLECULAR PHARMACEUTICS (2020)
Characterization of the GI transit conditions in Beagle dogs with a telemetric motility capsule
Mirko Koziolek et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2019)
Effect of Amorphous Nanoparticle Size on Bioavailability of Anacetrapib in Dogs
Filippos Kesisoglou et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Bridging in vitro dissolution and in vivo exposure for acalabrutinib. Part I. Mechanistic modelling of drug product dissolution to derive a P-PSD for PBPK model input
Xavier J. H. Pepin et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2019)
Bridging in vitro dissolution and in vivo exposure for acalabrutinib. Part II. A mechanistic PBPK model for IR formulation comparison, proton pump inhibitor drug interactions, and administration with acidic juices
Xavier J. H. Pepin et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2019)
Bioavailability, Biotransformation, and Excretion of the Covalent Bruton Tyrosine Kinase Inhibitor Acalabrutinib in Rats, Dogs, and Humans
Terry Podoll et al.
DRUG METABOLISM AND DISPOSITION (2019)
Mechanistic Study of Belinostat Oral Absorption From Spray-Dried Dispersions
Aaron Stewart et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Polymer-Mediated Drug Supersaturation Controlled by Drug-Polymer Interactions Persisting in an Aqueous Environment
Yuejie Chen et al.
MOLECULAR PHARMACEUTICS (2019)
Impact of Drug-Rich Colloids of Itraconazole and HPMCAS on Membrane Flux in Vitro and Oral Bioavailability in Rats
Aaron M. Stewart et al.
MOLECULAR PHARMACEUTICS (2017)
Mechanistic Design of Chemically Diverse Polymers with Applications in Oral Drug Delivery
Laura I. Mosquera-Giraldo et al.
BIOMACROMOLECULES (2016)
Inventory of oral anticancer agents: Pharmaceutical formulation aspects with focus on the solid dispersion technique
E. Sawicki et al.
CANCER TREATMENT REVIEWS (2016)
Physiologically Based Absorption Modeling for Amorphous Solid Dispersion Formulations
Amitava Mitra et al.
MOLECULAR PHARMACEUTICS (2016)
Characteristics of the Human Upper Gastrointestinal Contents in the Fasted State Under Hypo- and A-chlorhydric Gastric Conditions Under Conditions of Typical Drug - Drug Interaction Studies
Chara Litou et al.
PHARMACEUTICAL RESEARCH (2016)
Assessment of the Amorphous Solubility of a Group of Diverse Drugs Using New Experimental and Theoretical Approaches
Luis Almeida e Sousa et al.
MOLECULAR PHARMACEUTICS (2015)
pH-Dependent Drug-Drug Interactions for Weak Base Drugs: Potential Implications for New Drug Development
L. Zhang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
The effect of HPMCAS functional groups on drug crystallization from the supersaturated state and dissolution improvement
Keisuke Ueda et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2014)
Drug-drug interactions with tyrosine-kinase inhibitors: a clinical perspective
Roelof W. F. van Leeuwen et al.
LANCET ONCOLOGY (2014)
Dissolution media simulating the proximal canine gastrointestinal tract in the fasted state
Marcel Arndt et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2013)
Prevalence of Acid-Reducing Agents (ARA) in Cancer Populations and ARA Drug-Drug Interaction Potential for Molecular Targeted Agents in Clinical Development
Gillian S. Smelick et al.
MOLECULAR PHARMACEUTICS (2013)
Development of a Canine Model to Enable the Preclinical Assessment of Ph-dependent Absorption of Test Compounds
R. Marcus Fancher et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
Hydroxypropyl Methylcellulose Acetate Succinate-Based Spray-Dried Dispersions: An Overview
Dwayne T. Friesen et al.
MOLECULAR PHARMACEUTICS (2008)
Oral absorption of poorly water-soluble drugs: Computer simulation of fraction absorbed in humans from a miniscale dissolution test
Ryusuke Takano et al.
PHARMACEUTICAL RESEARCH (2006)
Dose-dependent control of intragastric pH by pantoprazole, 10, 20 or 40 mg, in healthy volunteers
R Tutuian et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
Share Paper
